Barclays PLC Has $153,000 Holdings in The Beauty Health Company (NASDAQ:SKIN)

Barclays PLC increased its holdings in The Beauty Health Company (NASDAQ:SKIN) by 224.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,103 shares of the company’s stock after buying an additional 73,425 shares during the period. Barclays PLC owned 0.09% of Beauty Health worth $153,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. SG Americas Securities LLC acquired a new position in Beauty Health in the 3rd quarter valued at $37,000. Caprock Group LLC bought a new position in shares of Beauty Health in the second quarter worth $38,000. Sanctuary Advisors LLC acquired a new position in Beauty Health in the second quarter valued at about $47,000. Orion Portfolio Solutions LLC bought a new stake in Beauty Health during the third quarter worth about $65,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in Beauty Health during the second quarter worth about $105,000. 93.26% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group upped their price target on shares of Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.55.

Beauty Health Stock Performance

NASDAQ:SKIN opened at $1.90 on Wednesday. The Beauty Health Company has a twelve month low of $0.91 and a twelve month high of $5.17. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The stock’s 50-day simple moving average is $1.57 and its 200 day simple moving average is $1.62. The firm has a market capitalization of $235.83 million, a PE ratio of -4.52 and a beta of 0.81.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.